Open | - |
Close | - |
Volume / Avg. | 0 / 7.789K |
Day Range | - - - |
52 Wk Range | 0.680 - 2.320 |
Market Cap | $4.657M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 0.27% |
Days to Cover | 1.45 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagenic Therapeutics (NASDAQ: PTIX) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Protagenic Therapeutics (NASDAQ: PTIX) was reported by Maxim Group on Friday, October 29, 2021. The analyst firm set a price target for 4.00 expecting PTIX to rise to within 12 months (a possible 280.95% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Protagenic Therapeutics (NASDAQ: PTIX) is $1.05 last updated March 8, 2024 at 9:13 AM EST.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.